Skip to main content

Leave to Appeal in patent dispute over C-RAD’s entitlement to patents granted

Written by Customer Service on . Posted in Public Companies.

The Stockholm Patent and Market court confirmed in its verdict dated July 26, 2019, C‑RAD’s right to the patent application “Ionizing radiation detecting device”. The
opposing party, Beamocular AB, appealed the verdict. Now, the appeal court (Svea Hovrätt- Patent- och marknadsöverdomstolen) has granted leave to appeal.Leave to appeal is granted in the large majority of appeals in patent cases. The decision to leave grant to the appeal does in itself not indicate how the appeal court will rule after having heard the case on the merits.The appeal court will try the case based on the same material as in the district court. C‑RAD’s view is that nothing new has happened, and C-RAD’s assessment of its chances to successfully defend its right to the invention remains unchanged.Background
The background to the dispute relates to a patent entitlement lawsuit that C-RAD filed against Beamocular with the Patent and Market Court in Stockholm on May 22, 2017. C-RAD claims the ownership rights of the invention described in the patent application “Ionizing radiation detecting device” from Beamocular. The ownership in the rights of the patent does not have a significant impact on C‑RADs long-term strategy as the patent is not utilized at the moment.For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email tim.turn@c-rad.comAbout C-RADC-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD (Shanghai) Medical Device Co Ltd in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.For more information on C-RAD, please visit http://www.c-rad.comAttachmentPR 20191203 Leave to Appeal

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.